连续性血液灌流对敌草快中毒患者的效果及意义
研究纳入河北医科大学附属哈励逊国际和平医院急诊科2018年5月至2021年8月收治的86例急性敌草快中毒患者,随机分为间断血液灌流组(40例)和持续血液灌流组(46例)。所有患者入院24小时内接受基础治疗和连续性静脉-静脉血液滤过,间断组在2小时内开始血液灌流,每次2小时、每8小时一次、共3次;持续组持续血液灌流至尿样中无敌草快成分。持续组治疗后各时间点NGAL、sCD14-st、CK-MB、IL-18、乳酸、SCr均显著低于间断组,28天死亡率显著低于间断组(26.09% vs 52.50%,P=0.007)。
要点
- 持续血液灌流组28天死亡率26.09%(12/46)显著低于间断血液灌流组52.50%(21/40),Log-Rank检验χ²=7.288,P=0.007。
- 治疗24小时后持续组NGAL为345.90±30.75 μg/L、sCD14-st为1941.88±298.02 ng/L、CK-MB为30.67±9.11 U/L、IL-18为139.49±16.29 ng/L,均显著低于间断组(均P<0.05)。
- 治疗3天后持续组乳酸为2.98±0.26 mmol/L、SCr为125.01±24.24 μmol/L,均显著低于间断组(均P<0.05)。
- 两组治疗后各时间点PaO2水平无显著差异。
- 间断组NGAL、sCD14-st、CK-MB、IL-18在治疗后24小时达峰,乳酸和SCr在治疗后3天达峰。
适用人群与场景
- 2018年5月至2021年8月河北医科大学附属哈励逊国际和平医院急诊科收治的急性敌草快中毒患者86例。
处置流程与药物剂量
- 所有患者入院24小时内接受基础治疗和连续性静脉-静脉血液滤过。
- 间断血液灌流组:入院2小时内开始血液灌流,每次2小时,每8小时一次,共3次。
- 持续血液灌流组:持续血液灌流至尿样中无敌草快成分。
研究设计与关键结果
- 研究类型为随机对照研究,纳入86例急性敌草快中毒患者,随机分为间断血液灌流组(40例)和持续血液灌流组(46例)。
- 治疗前两组血清NGAL、sCD14-st、乳酸、PaO2、SCr、CK-MB、IL-18水平无显著差异。
- 治疗24小时后持续组NGAL(μg/L)345.90±30.75 vs 间断组404.24±38.79,sCD14-st(ng/L)1941.88±298.02 vs 2656.35±347.93,CK-MB(U/L)30.67±9.11 vs 43.28±8.06,IL-18(ng/L)139.49±16.29 vs 177.98±27.85,均P<0.05。
- 治疗3天后持续组乳酸(mmol/L)2.98±0.26 vs 间断组3.72±0.49,SCr(μmol/L)125.01±24.24 vs 156.74±28.88,均P<0.05。
- 治疗后各时间点两组PaO2水平无显著差异。
- 28天死亡率持续组26.09%(12/46)vs 间断组52.50%(21/40),Log-Rank检验χ²=7.288,P=0.007。
证据类型、等级与局限
- 证据类型:随机对照研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,持续血液灌流可有效降低敌草快中毒患者血清sCD14-st、NGAL水平及28天死亡率,疗效良好。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To investigate the effect of continuous hemoperfusion (HP) on the levels of soluble CD14 isoform (sCD14-st) and neutrophil gelatinase-associated lipocalin (NGAL) on patients with diquat (DQ) poisoning and its significance.
METHODS: A total of 86 patients with acute DQ poisoning admitted to the department of emergency medicine, Harrison International Peace Hospital Affiliated to Hebei Medical University from May 2018 to August 2021 were enrolled and divided into the intermittent HP group (40 cases) and the continuous HP group (46 cases) according to the random number table method. All patients received basic treatment and continuous veno-venous hemofiltration (CVVH) within 24 hours after admission. On this basis, the intermittent HP group received HP treatment within 2 hours, lasting 2 hours each time for every 8 hours, 3 times in all; the continuous HP group received continued HP treatment until there was no DQ component in urine samples. Serum NGAL levels were detected in all patients before treatment and at 3 hours, 12 hours, 24 hours, 2 days, 3 days, 5 days, and 7 days after treatment. At the same time, serum sCD14-st, blood lactate (Lac), arterial partial pressure of oxygen (PaO2), serum creatinine (SCr), MB isoenzyme of creatine kinase (CK-MB) and interleukin-18 (IL-18) levels were detected before treatment and at 24 hours, 3 days, and 7 days after treatment. Kaplan-Meier survival curve was drawn to analyze the 28-day survival of patients.
RESULTS: Before treatment, there was no significant difference in serum NGAL, sCD14-st, Lac, PaO2, SCr, CK-MB and IL-18 levels between the two groups. With the prolongation of treatment, the serum levels of NGAL, sCD14-st, Lac, SCr, CK-MB and IL-18 in the intermittent HP group increased at first and then decreased. Serum levels of NGAL, sCD14-st, CK-MB and IL-18 reached their peaks at 24 hours after treatment, and the Lac and SCr levels reached their peaks at 3 days after treatment. In addition, the levels of the above indexes at each time point in the continuous HP group were all significantly lower than those in the intermittent HP group [after 24 hours of treatment: NGAL (μg/L) was 345.90±30.75 vs. 404.24±38.79, sCD14-st (ng/L) was 1 941.88±298.02 vs. 2 656.35±347.93, CK-MB (U/L) was 30.67±9.11 vs. 43.28±8.06, IL-18 (ng/L) was 139.49±16.29 vs. 177.98±27.85; 3 days of treatment: Lac (mmol/L) was 2.98±0.26 vs. 3.72±0.49, SCr (μmol/L) was 125.01±24.24 vs. 156.74±28.88; all P < 0.05]. However, there was no significant difference in PaO2 levels between the two groups at each time point after treatment. The Kaplan-Meier survival curve showed that the 28-day mortality of patients in the continuous HP group was significantly lower than that in the intermittent HP group [26.09% (12/46) vs. 52.50% (21/40); Log-Rank test: χ 2 = 7.288, P = 0.007].
CONCLUSIONS: Continuous HP could effectively reduce serum sCD14-st, NGAL levels and 28-day mortality in patients with DQ poisoning, with good curative effect.
参考来源
- Wang W, Liu Q, Xu W, et al. [Effects and significance of continuous hemoperfusion on patients with diquat poisoning]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2022. PMID: 36567591. doi:10.3760/cma.j.cn121430-20210902-01311
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。